Case Report: Treatment of Pruritus in Primary Sclerosing Cholangitis with Upadacitinib

A single clinical case report describes the successful treatment of refractory pruritus in a patient with primary sclerosing cholangitis using the JAK1 inhibitor upadacitinib. The report, authored by figshare admin karger and last updated in April 2026, details the patient's history, treatment timeline, and a 27-month symptom-free period. The dataset is a 24.8 KB DOCX file containing the full text of the case report.

Use Cases

• Analyze the clinical narrative for treatment response patterns based on the detailed case presentation.
• Extract key medical terms and outcomes for literature reviews on primary sclerosing cholangitis management.
• Study the structure and content of a formal medical case report for educational or methodological purposes.

Strengths

• Report details a specific 27-month symptom-free follow-up period.
• The dataset is openly available under a CC-BY-4.0 license.
• File format is a common, accessible DOCX document.

Limitations

• Dataset is a single case report (n=1), limiting statistical generalizability.
• Row count and column-level documentation are unknown.
• Data may reflect the specific bias inherent to a single clinical observation.

Provenance

Source

figshare

Collection Method

Likely a published or submitted medical case report uploaded to the repository.

Freshness

Last updated 2026-04-18 07:55:27